In Bavaria, biosimilar competition led to rheumatic patients receive faster access to biological therapy

Accelerating the biosimilar medicines access journey… 28 March 2019 Biosimilar medicines have significantly increased equity of access to important…
Ready to drive access to medicines 21 June 2019 Medicines for Europe is ready to engage with the EU…
SPC manufacturing waiver, Competition policy,… 25 April 2018 Key authorities, lawyers and industry leaders discussed today in London…
Competition policy essential for access to medicines 28 January 2019 Medicines for Europe welcomes the publication of the European Commission…